High glucose concentrations induce oxidative stress by inhibiting Nrf2 expression in rat Müller retinal cells in

Jesús Silvestre Albert-Garay1, Juan Rafael Riesgo-Escovar2, Rocío Salceda3

  • 1Departamento de Neurodesarrollo y Fisiología, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, 04510, CDMX, Mexico. silvestre.alb@gmail.com.

Scientific Reports
|January 25, 2022
PubMed

Insights

High glucose levels increase oxidative stress and alter Nrf2 regulation in Müller cells, impacting diabetic retinopathy progression. This suggests NF-kB activation plays a role in Nrf2 dysfunction.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Metabolic Disorders

Background:

  • Diabetic retinopathy (DR) is a diabetes complication linked to oxidative stress.
  • Nuclear factor erythroid-2-related factor 2 (Nrf2) regulates redox homeostasis.
  • Müller cells (MC) are crucial for retinal stability.

Purpose of the Study:

  • To investigate the impact of high glucose on reactive oxygen species (ROS) and Nrf2 in rat MC.
  • To explore the role of nuclear factor-kappa B (NF-kB) in high glucose-induced cellular changes.

Main Methods:

  • Rat MC were exposed to normal (5 mM) or high glucose (25 mM) for varying durations.
  • Assessed cell viability, ROS production, Nrf2 expression, and Nrf2 target gene mRNA levels.
  • Measured glutathione levels, catalase activity, and NF-kB p65 subunit levels.

Main Results:

  • High glucose increased ROS levels from 12 to 48 hours without affecting cell viability.
  • A transient decrease in Nrf2 levels and its target gene expression was observed after 3 hours of high glucose exposure.
  • High glucose elevated NF-kB p65 levels and its target genes, while glutathione and catalase activity initially decreased then increased.

Conclusions:

  • High glucose concentrations disrupt MC redox balance by transiently downregulating Nrf2.
  • NF-kB activation appears to mediate the high glucose-induced alterations in Nrf2 regulatory capacity.
  • These findings highlight potential therapeutic targets for mitigating diabetic retinopathy-associated oxidative stress.

Related Concept Videos